Skip to content
SEC filings edition: Friday, November 13, 2026 · 767 companies with filings Publisher's serviceBoardeon, your AI board · Hire your board →
Monday, November 16, 2026Every business day from SEC EDGAR
SEC EDGAR · Nov 13, 2026 1bankruptcies 11delisting notices 12late filings 43leadership changes 6IPO filings 199private raises 90earnings releases
Company page · CIK 1806540 · LYCA

Lycia Therapeutics, Inc.

Filing with the SEC SEC-reporting company South San Francisco, CA Nasdaq
An email when it files something new with the SEC. Your account

What this means

  • Private capital raiseOn Jun 25, 2026 the company filed Form D. A Form D is a notice of an exempt offering, not an SEC approval; the figures are the issuer’s own.

What to do next

Guides from the Companies Daily newsroom, picked for what the register shows.

Name as filed
Lycia Therapeutics, Inc.
CIK
0001806540
Tickers
LYCA
Kind of filer
SEC-reporting company
Status
Filing with the SEC
State of incorporation
Delaware
Industry (SIC)
2836 · Biological products, (no diagnostic substances)
Industry: D · Manufacturing →
Fiscal year ends
December 31
Last annual report
None in our data
Last quarterly report
—
Bankruptcy reported
Not in our data
Last edition event
Oct 5, 2026

Filing history

Newest first: the filings we classify (8-K items, late filing notices, delistings, deregistration, IPO registrations, Schedule 13D, Form D, annual and quarterly reports), from Jan 1, 2023. All documents, including those we do not classify, are in the EDGAR filing index.

  • IPO prospectus (424B4): Final prospectus (424B4)
    Form 424B4 · filed Oct 23, 2026 · filing
  • IPO registration filed: Registration statement (S-1)
    Form S-1 · filed Oct 5, 2026 · filing
  • Private raise (Form D)
    Form D · items 06b · filed Jun 25, 2026 · filing
  • Private raise (Form D)
    Form D · items 06b · filed May 23, 2024 · filing